MGAT3 and breast cancer: To investigate potential MGAT3 substrates with significantly altered protein levels in MDA-MB-231 cells and their role in breast cancer, a proteomic analysis was performed using MDA-MB-231 cells that were engineered to overexpress MGAT3 (MGAT3/231) [32].